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Abstract  
 
There is a need for low-cost nanoparticle materials in the context of new technologies for 
catalyst development. The purpose of this work was to recombinantly produce a 45- amino acid 
long metal binding peptide that is useful for nanoparticle synthesis.  Using splicing by overlap 
extension PCR, a synthetic gene containing the fusion of the metal binding peptide with Green 
Fluorescent Protein (GFPUV) was constructed.  The metal binding peptide, fused to reporter 
protein GFPUV, was expressed using high cell density fermentation. Palladium nanoparticles of 
an average diameter of 1.18 ± 0.45 nm were synthesized by using the crude cell extract 
containing the fusion protein. Nanoparticle synthesis was also done using desalted samples 
(removal of medium components) as well as enriched fractions from ion exchange 
chromatography purification. In all cases, palladium, gold and palladium-gold nanoparticles 
were successfully synthesized with good particle size for catalysis applications, control of 
diameter, and lack of other metal precipitants, respectively.  
This work illustrates that metallic nanoparticles can be synthesized using the soluble cell 
extract containing the fusion protein without extensive purification or cleavage steps.  
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1. Introduction 
 
1.1. Peptides  
A peptide is a small protein with a specific sequence of amino acid residues. There is a total pool 
of 20 different natural amino acids that proteins or peptides are built from. All the common 
amino acids (except for proline) have the same general structure, where there is a central carbon 
atom (Ca) that is covalently bonded to an amino group (NH2), a carboxyl group (COOH), a 
hydrogen atom and a side group (R)1.  
 
 
 
 
 
 
 
 
Figure 1. General structure of an amino acid 1 
 
1.2.Metal binding peptide  
The sequence used for this work is 
TSNAVHPTLRHLGGGGTSNAVHPTLRHLGGGGTSNAVHPTLRHLM. It contains the 
TSNAVHPTLRHL domain, which is a known palladium binding sequence (Pd4)2. Also, four 
glycine spacers are used to link the Pd4 domains, a common practice when concatenating amino 
acid sequences3. This peptide can be used to synthesize palladium and gold nanoparticles for a 
variety of catalysis applications4. The Pd4 peptide has histidine (H) residues at the six and eleven 
positions, which are expected to help anchor the peptide to metallic surfaces5. 
 
 
Cα C 
H 
N 
OH 
O H 
H 
R 
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1.3.Nanoparticles 
 
By definition, nanotechnology is the science that deals with matter at the scale of 1 billionth of a 
meter (10-9 m), as well as the study of the modification of matter at the atomic and molecular 
scale 6. Nanoparticles are “the most fundamentals components in the fabrication of a 
nanostructure, and are far smaller than the world of everyday objects, but bigger than an atom or 
a simple molecule that are governed by quantum mechanics”6. Most nanoparticles are between 
the sizes of 1 and 100 nm7. Metallic nanoparticles are widely utilized in biomedical sciences and 
engineering7. The properties of metallic nanoparticles can have significant advantages over bulk 
metals, such as lower melting points and higher specific surface areas6.  
 
1.4.Reduction methods for nanoparticle synthesis  
Among the liquid phase synthetic methods for nanoparticles there are liquid/liquid and 
sedimentation methods6. Chemical reduction method is considered one of the  liquid/liquid 
methods and includes polyol, organic acids, sodium borohydride and sugar as materials involved 
in synthesis6.  This chemical reduction method has many advantages that include the use of 
simple equipment and it has a high yield of nanoparticles with a low cost and little time6.  The 
basic principle of this method relies on the reduction of the metal ions to their 0 oxidation states, 
in the case of palladium, Pd2+à Pd0.  
 
1.5. Recombinant nanoparticles  
 
Nanoparticles synthesized from recombinantly produced proteins show excellent potential for a 
wide variety of nanotechnology applications8. Bio inspired inorganic nanomaterials have the 
potential to create novel therapeutics, drug delivery systems and catalysts2. Nanoparticles made 
by peptide-directed synthesis are an example of novel bio inspired materials since nanoparticle 
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morphology is dictated by a biological component. Examples of present recombinant 
nanoparticles include PLGA nanoparticles to induce the killing of Leishmania9 and high-density 
lipoprotein Nanoparticles10.  
 
Traditional methods used for synthesis of nanoparticles involve very energy consumptive 
conditions, so the use of peptides for this purpose is considered a sustainable alternative11.  
Despite the potential of recombinant nanoparticle platforms, the number of identified 
recombinant proteins suitable for nanoparticle synthesis applications is very small. Most of the 
literature describes the use of peptides that are synthesized via solid phase chemistry.  Indeed, to 
date less than 20 references on peptides derived from recombinant sources have been used to 
direct nanoparticle synthesis.  Also, to our knowledge no reference describes the use of a peptide 
fused to either the N- or C- terminus of a reporter protein to direct nanoparticle synthesis.  
 
There are many proposed advantages to the use of a recombinant platform for nanoparticle 
synthesis when compared to the use of peptides chemically synthesized. These include cost 
effectiveness, homogeneity and easy modification8.  Other features may be incorporated in the 
construction which allows for the quantification of the product, since traditional techniques like 
SDS PAGE and mass spectroscopy require additional effort to track the metal binding peptide 
through the bioprocess.  
 
1.6. Escherichia Coli and Green Fluorescent Protein (GFPUV) 
Escherichia coli is widely used for protein expression for a variety of reasons. E. coli is 
inexpensive, it is relatively simple to grow and it has well-known genetics12. The media can be 
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made with easily accessible and cheap components13. Also, the transformation protocol with 
external DNA is very simple and straightforward. Other characteristic that makes E.coli very 
favorable to use is that fermentation processes at large scales exist and high cell densities are 
achieved in industry14.  The main disadvantage of using E.coli is its inability to perform post 
translational modifications, and potential issues of product isolation15.  
 
The reporter protein GFPUV has plenty of useful applications. The most noticeable property is its 
fluorescence, which can be used to monitor upstream and downstream processing 16. In addition, 
GFPUV has a stability that is considered an important advantage when used as a fusion partner16.  
It is also easily purified via Immobilized Metal Affinity Chromatography and Aqueous Two 
Phase Extraction17. 
 
1.7. Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) is a molecular biology technique to amplify a piece of 
DNA, generating thousands to millions of copies of the DNA sequence 18. There are a few 
components that are indispensable for PCR18:  
• Polymerases, which are enzymes that able to put together DNA building blocks.  
• Nucleotides consisting of the four bases adenine, thymine, cytosine and guanine, 
which are referred to as DNA building blocks. 
• Primers or small fragments of DNA, to initiate the PCR reaction.  
• Original fragment of DNA, that serves as the template.  
There are three basic steps for PCR: denaturation, annealing and extension. In denaturation, the 
two-stranded template DNA is heated at a high temperature (~90-98°C) to separate it into single 
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strands18. In annealing, the primers attach to the DNA template strands at a lower temperature 
(~72°C). In extension, a new complimentary copy strand of DNA is made using the polymerase 
enzyme by adding nucleotides to the end of the annealed primers18. These three steps are 
repeated between 20-40 cycles. Splicing by overlap extension PCR (SOE PCR) is a method in 
which PCR products that are made to share a common sequence at one end are recombined or 
spliced together without additional nucleotides typical of restriction cloning 19.  
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2. Materials and Methods 
 
2.1. Design of primers for SOE PCR  
 
The sequence of the desired metal binding peptide (MBP) is 
TSNAVHPTLRHLGGGGTSNAVHPTLRHLGGGGTSNAVHPTLRHLM. A methionine 
residue was added in the C-terminus of the peptide in order to allow, if desired, cyanogen 
bromide cleavage of the peptide once it is expressed.   
 
A DNA fragment encoding the MBP was designed according to the codon preference of E. coli 
and was purchased from Integrated DNA Technologies (Coralville, IA). Using a three step PCR 
scheme, as shown in Figure 2, an MBP-GFPUV synthetic gene was created.  In the first step, an 
NcoI restriction site is introduced in the 5’ end of the MBP with primer Forward 1 along with 
GFPuv in the 3’ end with the primer Reverse 1. In step 2, the MBP overlap region is introduced in 
the 5’ end of GFPuv using the primer Forward 2 and Histidine 6 tag with an EcoRI restriction site 
in the 3’ end using the primer Reverse 2. The two PCR products were spliced together in a third 
PCR using the Forward 1 and Reverse 2 primers. The primers used in the PCRs are listed in 
Table 1.  
Table 1. List of primers 
Forward 1  5’-GACGGTAGAACCATGGGTACTTCCAATGCCGTCCA-3’ 
Reverse 1   5’-GTGAAAAGTTCTTCTCCTTTACTCATTAAGTGACGCAAGGTCGG-3’ 
Forward 2  5’-CCGACCTTGCGTCACTTAATGAGTAAAGGAGAAGAACTTTTCAC-3’ 
Reverse 2 5’-TGCGAATTCTTAATGGTGATGGTGATGGTGTTTGTAGAGCTCATC-3’ 
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Figure 2. Illustration of the cloning by splicing by overlap extension PCR strategy 
 
2.2.Recombinant expression vector construction of MBP-GFPuv  
Splicing by overlap extension polymerase chain reaction (SOE PCR) was performed using the 
Q5® High-Fidelity 2X Master Mix 25 µL reaction protocol from New England Biolabs 
(Ipswich, MA). The components that were mixed for the PCR reaction were: 12.5 µL of the Q5® 
Master Mix, 1.25 µL forward primer, 1.25 µL reverse primer, 5 µL of the template DNA and 5 
µL of nuclease-free water. The final PCR product contains the MBP fused to GFPUV from 
Clonetech (Mountain View, CA).  
 
The PCR product and pBAD plasmid were double digested using EcoRI-HF® and NcoI-HF® 
restriction enzymes from New England Biolabs. Both products were recovered using a two-tier 
1.2% agarose FlashGel cassette and Recovery buffer from Lonza (Rockland, ME).  
 
Finally, ligation of the digested PCR product and the digested pBAD occurred overnight using 
T4 DNA Ligase enzyme and T4 DNA Ligase Reaction buffer (New England Biolabs) at 14°C. 
The recombinant plasmid construction is illustrated in Figure 4.  
GFPuvMBP	gene5’- -3’ 5’- -3’
NCoI GFP	5’ EcoRIMBP	3’
PCR	1 PCR	2
PCR	3MBP	gene
MBP	gene GFPuv
GFPuv
GFP	5’
EcoRINcoI MBP	gene GFPuv
NcoI EcoRI
MBP	3’
EcoRI
NCoI
GFP	5’
5’- -3’
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Figure 3. Temperature gradient for SOE PCR 
 
The ligation product was transformed using the heat shock method. Using 50 µL of 10-Beta E. 
coli competent cells from New England Biolabs, 5µL of the ligation product was added and the 
mixture was placed in ice for 30 minutes. The cells were heat shocked at 42°C for 30 seconds, 
then placed on ice for 5 minutes. 950 µL of SOC Outgrowth medium was added to the cells and 
then incubated in a shaker for 60 minutes at 37°C. The cells were plated on LB agar media 
containing 50 µg/mL ampicillin and 2 mg/mL arabinose. The plates were incubated overnight at 
37°C and the product was checked for green fluorescence using UV light.  
 
9 
	
 
Figure 4. Schematic illustration of the plasmid construction 
 
2.3.Fed-batch fermentation 
A single colony of the transformed cells was inoculated into 5 mL of Lysogeny Broth (LB) 
media and 50µg/mL ampicillin and incubated overnight in a shaker at 37°C. Then, 1 mL of this 
culture was inoculated in a shake flask containing 100 mL of LB media and 50 µg/mL ampicillin 
and incubated overnight. Once the inoculum for the fed batch fermentation was prepared in the 
shake flask, 50 mL of the overnight culture was added to 1.5 L of LB media in a 3 L Applikon 
bioreactor with BioXpert Advanced software. The bioreactor was fed with 500 g/L sterilized 
glucose solution. The temperature in the reactor was maintained at 37°C using a heating jacket 
and cooling loop. The pH was maintained at 6.8 using 7 M of NH4OH. Bugeye optical density 
sensor (BugLab, Foster City, CA) was used for measuring the optical density.  After 16 hours of 
fermentation, the culture was induced with 10 mM arabinose. Four hours after induction, the 
fermentation was stopped and the cells were harvested by centrifugation at 5000 x g and 3 °C 
and were stored at -80°C.  
MBP	gene GFPuv
NcoI EcoRI
pBAD myc- His	B
4094	bp
EcoRI
NcoI
Digested		with
NcoI,	EcoRI
Digested		with
NcoI,	EcoRI
NcoI EcoRI
Digested	pBAD
Ligation
pBAD-MBP-GFP
MBP	gene GFPuv
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2.4.Desalting and purification  
For some samples, excess salts in the clarified lysate were removed using a 3.5 kDa MWCO 
dialysis membranes from Spectrum Laboratories (Rancho Dominguez, CA). The clarified lysate 
was processed using an ÄKTA FPLC System from Amersham Biosciences. A HiTrap DEAE FF 
column from GE Healthcare was equilibrated with IEX DEAE Buffer A (25 mM Tris-HCl, 
pH=8).  The clarified lysate (20 mL) was loaded at a flow rate of 0.5 mL/min. The column was 
washed with 20 column volumes (CV) at a flow rate of 1 mL/min with the Buffer A previously 
mentioned. After the column was washed and lysate loaded, enrichment proceeded via a 
stepwise elution with IEX DEAE Buffer B (25 mM Tris-HCl, 1 M NaCl, pH=8). Fractions of 3 
mL were collected, and the ones that fluoresced green under UV light were analyzed using SDS-
PAGE gel and a fluorimeter.  
 
2.5. Other Methods 
After the cells were harvested, 7 grams of pellet were resuspended in 40 mL of deionized water 
and then lysed on ice using Q125 Sonicator at 40% amplitude with 10 seconds pulse and 15 
seconds rest period for a total of 20 minutes.  
 
The total concentration of protein in the clarified lysate was determined using the DCTM Protein 
Assay from Bio-Rad (Hercules, CA) following the instructions from the manufacturer. The 
standard curve that was used, which was made using bovine serum albumin, can be found in the 
Appendix.  
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Densitometric analysis was performed using ImageJ software with an 12.5% sodium dodecyl 
polyacrylamide gel electrophoresis (SDS-PAGE) band corresponding to the molecular weight of 
the MBP-GFPUV.  
 
The fractions collected from IEX chromatography were used for fluorometric measurements 
using a RF-Mini 150 Recording Fluorometer from Shimadzu (Kyoto, Japan) with excitation and 
emission filters of 395 nm and 510 nm, respectively.  The instrument was zeroed with deionized 
water and a maximum value of 1000 RFU (relative fluorescence units) with a reference sample 
of highly concentrated GFPUV. 
 
2.6. Nanoparticle synthesis and characterization  
The protocol used for synthesis of nanoparticles was adapted from previous work  
Palladium nanoparticles were synthesized by first mixing for 30 minutes at room temperature: 
750 µL of double distilled water, 230 µL of the clarified lysate and 5 µL of 0.1 M potassium 
tetrachloropalladate (K2PdCl4). After Pd complexation, 40 µL of 1.0 M sodium borohydride 
(NaBH4) was added to reduce the Pd2+ to Pd0 nanoparticle. The particles were then left 
undisturbed for 1 hour prior to testing and characterization. 
 
The palladium-gold (PdAu) nanoparticles were synthesized by adding gold at a 1:1 ratio with 
palladium. In this case, 750 µL of double distilled water, 230 µL of the clarified lysate, 2.5 µL of 
0.1 M potassium tetrachloropalladate (K2PdCl4) and 2.5 µL of 0.1 M hydrogen tetrachloroaurate 
(HAuCl4). This mix was left undisturbed for 30 minutes at room temperature, before adding 40 
µL of 1.0 M sodium borohydride. The particles were tested and characterized 1 hour later.  
12 
	
TEM samples were prepped by placing droplet of as synthesized material on Cu TEM grids 
coated with a thin layer of C (Ted Pella, Inc.).  After one minute, the droplet was wicked away 
with a Kimwipe, leaving a non-aggregated layer of physisorbed nanoparticles.  Images and 
electron dispersive spectroscopy were performed in scanning transmission mode operating at 300 
kV. 
2.7.Determination of size of nanoparticles 
The analysis of the TEM images obtained of the nanoparticles was done using ImageJ software. 
Using the area of the particles measured from ImageJ, the diameter of each one was calculated 
with the formula A=pr2, where d=2r.  
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3. Results and discussion  
3.1.Recombinant expression vector construction of MBP-GFPuv 
The PCR product of MBP-GFPuv has a size of 936 bp. A DNA fragment between 800 and 1200 
bp was obtained using a single-tier 1.2% agarose Lonza’s FlashGel ™ Cassette as shown in 
Figure 5.  
 
 
 
 
 
 
 
 
Figure 5.  1.2% agarose gel of the PCR product MBP-GFPUV 
 
The recombinant plasmid was transformed into 10-beta E. coli cells. Plated cells were visibly 
green under UV light after overnight growth on an LB agar plate containing 50 µg/mL ampicillin 
and 2 mg/mL arabinose (data not shown). 
3.2.Fed-batch fermentation 
Fed-batch fermentation was performed in order to reach high cell density. Figure 6 shows the 
plot of OD600 as a function of time in hours. A terminal OD600 of 22.1 was reached during the 
fed-batch fermentation run which yielded a total of 75 g cell pellet. 
1250 bp 
800 bp 
936 bp 
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Figure 6. Growth profile of E. coli containing the MBP-GFPUV during fed-batch fermentation. 
“F” indicates the start of the feed into the bioreactor and “I” indicates the time of the induction. 
 
Figure 7 is an SDS-PAGE gel of the clarified lysate obtained from fed-batch fermentation. Using 
total protein assay, the protein concentration was estimated to be 7.4 mg/mL. It was determined 
using densitometry that the fusion protein content was approximately 11%.  
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Figure 7. SDS-PAGE gel. Lane 1, molecular weight marker. Lane 2, clarified lysate of crude 
extract, the circle marking the band corresponding to MBP-GFPUV 
 
3.3. Ion-exchange chromatography and fluorescence analysis  
Since the SDS-PAGE gel seen on Figure 8 was somewhat qualitative because the band presumed 
to be MBP-GFP may be several proteins of similar molecular weight, a fluorescence analysis 
was done on the IEX fractions corresponding to peaks “A”, “B” and “C” seen on Figure 8.  The 
fraction corresponding to peak B was expected to have the highest fluorescence based on 
visualization under UV light, and it was confirmed by the fluorometer measurements specified 
on Figure 9.  The fraction with 525 RFUs was used in later experiments to synthesize 
nanoparticles.  
37 kDa 
25 kDa 
31.5 kDa 
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Figure 8.  SDS-PAGE gel. Lane 1, molecular weight marker. Lane 2, IEX product fraction 
corresponding to peak “B”, the circle marking the band corresponding to MBP-GFPUV 
 
 
 
 
 
 
 
 
 
 
Figure 9. Ion-exchange chromatography of MBP-GFPUV 
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3.4. Nanoparticle synthesis and characterization 
3.4.1. Synthesis with crude clarified lysate 
The synthesis of nanoparticles was attempted with the crude clarified lysate obtained after fed 
batch fermentation. The synthesis was successful in the fact that small spherical Pd nanoparticles 
with an average size of 1.18 nm ± 0.21 nm were obtained, as seen in the size distribution 
histogram in Figure 10b. However, there were a lot of extra particulate matter in the sample. In 
Figure 11, it can be seen that there are larger particles in the sample that appear to be magnesium 
oxide (MgO), which led to believe that the magnesium from the medium was reduced with the 
Pd, but then oxidizes since the synthesis is done in aqueous solution.  
 
Figure 10. a) TEM image of the Pd nanoparticles with the crude cell lysate, b) size distribution 
histogram  
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Figure 11. Elemental analysis of the sample 
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3.4.2. Synthesis with desalted clarified lysate 
After seeing the results from the first synthesis attempt, it was concluded that a possible solution 
would be to desalt the sample to remove the extra components from the medium. The palladium 
particles obtained with the desalted sample had a bigger average diameter than the previously 
synthesized particles with the crude extract. Also, MBP-GFPUV was used successfully to 
synthesize gold and bimetallic palladium-gold nanoparticles. The Pd and Au nanoparticles are 
consistent with the previously made materials using peptides made by solid phase synthesis.   
 
 
Figure 12. a) TEM image of the Pd nanoparticles with desalted sample, b) size distribution 
histogram  
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Figure 13. a) HAADF image of the Pd nanoparticles with desalted sample, b) size distribution 
histogram 
 
Figure 14. a) TEM image of the Au nanoparticles with desalted sample, b) size distribution 
histogram 
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Figure 15. TEM analysis of PdAu nanoparticles with desalted sample, b) size distribution 
histogram 
 
 
Figure 16. HAADF image of PdAu nanoparticles with desalted sample 
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3.4.3. Synthesis with desalted and purified fractions 
The nanoparticle synthesis was done using enriched samples from IEX chromatography. 
Palladium nanoparticles with an average diameter of 2.6 ± 0.7 nm were synthesized. In addition, 
PdAu nanoparticles with an average diameter of 2.1 ± 0.7 nm were obtained.  
  
 
 
 
 
 
 
 
Figure 17. a) TEM image of the Pd nanoparticles with purified sample, b) size distribution 
histogram 
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Figure 18. a) HAADF image of PdAu nanoparticles with purified sample, b) size distribution 
histogram 
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4. Conclusions  
Nanoparticles synthesized using peptides that are produced recombinantly show potential for 
catalytic applications, but require some means of cost effective synthesis. The use of 
recombinantly produced peptides for nanoparticle synthesis represents a more sustainable 
method for large-scale production of these nanoparticles. This work has shown that nanoparticles 
of gold, palladium, and gold-palladium can be synthesized with three copies of Pd4 fused to 
GFPUV.  It motivates a comprehensive examination of the purity requirements of the peptide to 
effectively direct nanoparticle synthesis, because the degree of purity and properties of the 
nanoparticles has not been thoroughly correlated.   This work demonstrated that nanoparticles 
can be synthesized with soluble cell extract, desalted samples, and partially enriched samples.  
Determining the tolerance of byproducts with regard to catalytic efficiency would complete the 
investigation, accompanied by an economic analysis that would encompass MBP synthesis, 
nanoparticle synthesis, and quality of catalytic activity. 
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6. APPENDIX 
 
List of 20 amino acids and their notations 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Alanine (Ala)
V Valine (Val)
L Leucine (Leu)
I Isoleucine (Ile)
M Methionine (Met)
P Proline (Pro)
F Phenylalanine (Phe)
W Tryptophan (Trp)
Non-polar or hydrophobic R-group
D Aspartic Acid (Asp)
E Glutamic Acid (Glu)
Negatively charged R-groups at pH 6-7
N Asparagine (Asn)
Q Glutamine (Gln)
G Glycine (Gly)
T Threonine (Thr)
Y Tyrosine (Tyr)
S Serine (Ser)
C Cysteine (Cys)
Uncharged or hydrophilic R-groups
L Lysine (Lys)
R Arginine (Arg)
H Histidine (His)
Positively charged R- groups at pH 6-7
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BSA Standard curve for DCTM Protein Assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BSA (uL) BSA (mL) BSA (mg/mL) BSA (mg) BSA (ug) OD (750 nm)
0 0 0 0 0 0.013
20 0.02 0.187 0.00374 3.74 0.077
20 0.02 0.365 0.0073 7.3 0.141
20 0.02 0.73 0.0146 14.6 0.217
20 0.02 1.46 0.0292 29.2 0.581
BSA standard curve 
y	=	0.0191x	- 0.0039
R²	=	0.9774
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 5 10 15 20 25 30
OD
75
0
BSA	(μg)
BSA	Standard	Curve
Sample (uL) OD (750 nm) Mass (ug) Concentration (ug/uL)
3.5 0.454 23.973822 6.85
4 0.563 29.6806283 7.42
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Palladium nanoparticles (crude extract) (Figure 10) 
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Palladium nanoparticles (desalted) (Figure 12) 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 1.765 229.364 138 254 0.75 1.50
2 1.412 105.688 46 166 0.67 1.34
3 3.114 135.206 75 218 1.00 1.99
4 3.807 91.934 37 166 1.10 2.20
5 2.231 119.893 34 222 0.84 1.69
6 2.168 147.465 97 192 0.83 1.66
7 3.807 160.854 66 254 1.10 2.20
8 4.399 181.384 64 254 1.18 2.37
9 3.807 157.606 69 254 1.10 2.20
10 1.349 118.916 71 178 0.66 1.31
11 2.698 114.009 55 187 0.93 1.85
12 5.042 150.805 79 249 1.27 2.53
13 3.227 159.176 70 242 1.01 2.03
14 3.227 127.141 28 240 1.01 2.03
15 2.698 131.556 58 209 0.93 1.85
16 5.635 125.255 57 246 1.34 2.68
17 3.807 110.086 13 220 1.10 2.20
18 3.227 124.457 50 217 1.01 2.03
19 3.807 108.487 35 193 1.10 2.20
20 2.168 92.738 26 168 0.83 1.66
21 1.765 105.414 48 188 0.75 1.50
22 3.807 79.427 17 205 1.10 2.20
23 4.399 167.203 46 254 1.18 2.37
24 2.231 162.802 77 243 0.84 1.69
25 3.58 159.961 75 251 1.07 2.13
26 2.698 188.883 101 254 0.93 1.85
27 5.042 139.938 63 254 1.27 2.53
28 3.227 133 60 218 1.01 2.03
29 5.647 149.114 66 254 1.34 2.68
30 4.286 139.721 45 254 1.17 2.34
31 4.815 139.026 33 254 1.24 2.48
32 1.765 161.021 74 241 0.75 1.50
33 3.58 152.637 82 254 1.07 2.13
34 3.807 190.646 97 254 1.10 2.20
35 3.227 144.086 87 241 1.01 2.03
36 5.647 217.804 141 254 1.34 2.68
37 4.399 219.017 131 254 1.18 2.37
38 3.114 174.138 119 254 1.00 1.99
39 2.698 175.271 100 254 0.93 1.85
40 5.635 196.951 125 254 1.34 2.68
41 4.097 230.375 177 254 1.14 2.28
42 3.227 166.344 100 242 1.01 2.03
43 4.399 150.874 88 232 1.18 2.37
44 3.807 144.884 69 254 1.10 2.20
45 2.168 152.035 88 213 0.83 1.66
46 3.114 113.324 48 184 1.00 1.99
47 3.807 218.291 147 254 1.10 2.20
48 4.815 151.442 65 254 1.24 2.48
49 3.807 93.036 23 170 1.10 2.20
50 2.698 95.472 32 165 0.93 1.85
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Palladium nanoparticles image using HAADF (desalted) (Figure 13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 20.412 31.285 10 57 2.55 5.10
2 7.553 29.689 19 41 1.55 3.10
3 12.043 25.915 11 41 1.96 3.92
4 12.145 30.819 17 47 1.97 3.93
5 11.023 45.662 28 63 1.87 3.75
6 17.81 51.845 25 88 2.38 4.76
7 16.075 38.508 20 62 2.26 4.52
8 14.697 40.58 21 63 2.16 4.33
9 14.493 34.43 15 66 2.15 4.30
10 9.798 37.177 21 59 1.77 3.53
11 11.635 38.303 18 65 1.92 3.85
12 11.431 34.509 16 55 1.91 3.82
13 27.659 50.024 23 87 2.97 5.93
14 22.862 41.449 18 78 2.70 5.40
15 8.981 42.028 23 68 1.69 3.38
16 16.738 28.979 15 50 2.31 4.62
17 15.207 32.383 18 49 2.20 4.40
18 15.411 31.252 16 46 2.21 4.43
19 14.697 40.684 21 69 2.16 4.33
20 16.075 44.514 15 84 2.26 4.52
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Gold nanoparticles (desalted) (Figure 14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 18.992 245.694 110 254 2.46 4.92
2 10.142 244.91 119 254 1.80 3.59
3 12.881 236.215 93 254 2.02 4.05
4 10.142 247.982 126 254 1.80 3.59
5 16.507 213.161 68 254 2.29 4.58
6 12.881 215.931 51 254 2.02 4.05
7 10.142 199.4 59 254 1.80 3.59
8 11.359 253.629 207 254 1.90 3.80
9 7.658 207.377 71 254 1.56 3.12
10 25.863 231.725 72 254 2.87 5.74
11 7.201 167.746 42 254 1.51 3.03
12 7.658 214.646 81 254 1.56 3.12
13 4.361 152.448 42 254 1.18 2.36
14 7.658 134.977 41 254 1.56 3.12
15 6.491 139.09 38 254 1.44 2.87
16 7.658 154.682 52 254 1.56 3.12
17 10.142 174.31 26 254 1.80 3.59
18 7.201 192.447 58 254 1.51 3.03
19 8.621 223.438 114 254 1.66 3.31
20 4.488 157.938 44 254 1.20 2.39
21 9.686 169.683 45 254 1.76 3.51
22 7.201 159.218 39 254 1.51 3.03
23 6.263 157.789 42 254 1.41 2.82
24 7.658 150.868 37 254 1.56 3.12
25 10.142 142.395 40 254 1.80 3.59
26 10.142 144.098 48 254 1.80 3.59
27 10.142 117.28 22 254 1.80 3.59
28 11.359 98.402 6 254 1.90 3.80
29 5.426 163.949 66 254 1.31 2.63
30 4.361 179.686 92 254 1.18 2.36
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Palladium-gold nanoparticles (desalted) (Figure 15) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 5.785 15.938 0 255 1.48 2.96 Average	size	(nm)
2 6.87 31.156 0 255 1.48 2.96 2.12
3 6.87 75.733 0 255 0.84 1.68
4 2.221 40.029 0 255 1.18 2.36
5 4.39 12 0 255 1.20 2.40
6 4.507 81.103 0 255 0.94 1.88
7 2.763 71.495 0 255 1.36 2.71
8 5.772 17.685 0 255 1.28 2.56
9 5.165 23.588 0 255 1.62 3.24
10 8.239 99.922 0 255 1.20 2.40
11 4.507 0.731 0 255 0.94 1.88
12 2.763 58.388 0 255 1.28 2.56
13 5.165 49.088 0 255 0.94 1.88
14 2.763 91.752 0 255 1.03 2.05
15 3.306 35.859 0 255 1.01 2.02
16 3.19 46.457 0 255 0.94 1.88
17 2.763 121.542 0 255 0.91 1.81
18 2.583 73.95 0 255 0.84 1.68
19 2.221 115.64 0 255 0.91 1.81
20 2.583 150.45 0 255 0.84 1.68
21 2.221 90.436 0 255 1.01 2.02
22 3.19 47.49 0 255 1.11 2.23
23 3.9 126.656 0 255 1.03 2.05
24 3.306 131.484 0 255 0.85 1.71
25 2.286 122.458 0 255 0.85 1.71
26 2.286 106.61 0 255 1.28 2.56
27 5.165 18.488 0 255 1.28 2.56
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Determination of the size of Nanoparticles using ImageJ software.  
 
• Palladium (desalted and purified) (Figure 17) 
 
 
 
 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 8.947 23.721 0 255 1.69 3.38
2 9.987 0 0 0 1.78 3.57
3 3.329 55.781 0 255 1.03 2.06
4 5.41 0 0 0 1.31 2.62
5 9.987 26.562 0 255 1.78 3.57
6 6.658 63.75 0 255 1.46 2.91
7 4.577 63.75 0 255 1.21 2.41
8 6.242 80.75 0 255 1.41 2.82
9 8.322 25.5 0 255 1.63 3.26
10 7.282 0 0 0 1.52 3.04
11 14.148 37.5 0 255 2.12 4.24
12 8.947 5.93 0 255 1.69 3.38
13 3.537 15 0 255 1.06 2.12
14 5.41 4.904 0 255 1.31 2.62
15 4.577 0 0 0 1.21 2.41
16 6.658 19.922 0 255 1.46 2.91
17 8.218 6.456 0 255 1.62 3.23
18 7.282 65.571 0 255 1.52 3.04
19 17.061 13.994 0 255 2.33 4.66
20 3.849 0 0 0 1.11 2.21
21 4.369 24.286 0 255 1.18 2.36
22 6.346 29.262 0 255 1.42 2.84
23 13.836 28.759 0 255 2.10 4.20
24 15.397 5.169 0 255 2.21 4.43
25 13.108 16.19 0 255 2.04 4.09
26 5.306 25 0 255 1.30 2.60
27 5.41 19.615 0 255 1.31 2.62
28 15.709 10.132 0 255 2.24 4.47
29 5.306 50 0 255 1.30 2.60
30 6.242 59.5 0 255 1.41 2.82
31 7.49 24.792 0 255 1.54 3.09
32 4.369 18.214 0 255 1.18 2.36
33 4.369 36.429 0 255 1.18 2.36
34 4.577 17.386 0 255 1.21 2.41
35 13.836 26.842 0 255 2.10 4.20
36 7.49 24.792 0 255 1.54 3.09
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• Palladium with HAADF (desalted and purified) (Figure 18) 
 
 
 
 
 
 
 
 
 
 
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 4.967 84.618 71 93 1.26 2.51
2 2.17 86.413 84 100 0.83 1.66
3 2.129 86.353 78 101 0.82 1.65
4 6.574 85.676 81 100 1.45 2.89
5 3.047 85.863 85 100 0.98 1.97
6 12.041 84.461 64 93 1.96 3.92
7 4.32 84.966 76 95 1.17 2.35
8 7.638 85.014 68 100 1.56 3.12
9 20.535 83.984 60 88 2.56 5.11
10 8.306 85.98 83 101 1.63 3.25
11 7.283 85.358 81 97 1.52 3.05
12 3.673 85.562 77 98 1.08 2.16
13 3.694 85.492 84 99 1.08 2.17
14 3.694 85.09 85 92 1.08 2.17
15 5.009 85.479 85 101 1.26 2.53
16 2.63 85.484 85 96 0.91 1.83
17 4.341 86.524 81 103 1.18 2.35
18 11.165 84.794 66 100 1.89 3.77
19 1.461 86.843 85 97 0.68 1.36
20 6.49 85.35 70 100 1.44 2.87
21 3.089 85.696 85 100 0.99 1.98
22 10.205 85.147 80 100 1.80 3.60
23 9.099 84.908 71 95 1.70 3.40
24 2.838 86.809 76 101 0.95 1.90
25 3.151 86.675 85 101 1.00 2.00
26 3.673 86.165 85 103 1.08 2.16
27 9.412 85.357 81 97 1.73 3.46
28 5.176 85.024 85 91 1.28 2.57
29 1.649 87.392 85 100 0.72 1.45
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• Palladium-gold nanoparticles (desalted and purified) (Figure 18) 
  
 
Area Mean	 Min Max radius	(nm) diameter	(nm)
1 5.377 215.222 102 254 1.31 2.62
2 3.132 194.518 123 254 1.00 2.00
3 3.132 202.215 117 254 1.00 2.00
4 4.426 234.415 128 254 1.19 2.37
5 5.072 199.14 92 254 1.27 2.54
6 3.83 220.702 125 254 1.10 2.21
7 2.181 179.424 88 254 0.83 1.67
8 1.42 195.259 93 254 0.67 1.34
9 2.536 178.97 85 254 0.90 1.80
10 2.181 133.227 65 234 0.83 1.67
11 3.83 136.57 61 254 1.10 2.21
12 1.775 148.621 78 242 0.75 1.50
13 4.312 214.103 89 254 1.17 2.34
14 3.83 196.96 74 254 1.10 2.21
15 3.246 185.254 94 254 1.02 2.03
16 2.714 183.318 75 254 0.93 1.86
17 2.714 140.533 62 237 0.93 1.86
18 4.844 160.293 67 254 1.24 2.48
19 4.426 170.249 76 254 1.19 2.37
20 2.714 139.355 53 254 0.93 1.86
21 4.312 178.797 68 254 1.17 2.34
22 4.426 204.074 100 254 1.19 2.37
23 2.714 183.355 73 254 0.93 1.86
24 3.83 163.834 70 254 1.10 2.21
25 2.245 198.277 99 254 0.85 1.69
26 3.246 163.867 64 254 1.02 2.03
27 4.312 121.571 26 254 1.17 2.34
28 4.844 174.5 65 254 1.24 2.48
29 2.181 202.302 101 254 0.83 1.67
30 5.668 207.911 119 254 1.34 2.69
31 4.312 211.297 99 254 1.17 2.34
32 2.714 216.248 92 254 0.93 1.86
33 2.714 147.472 53 254 0.93 1.86
